- Home
- Media Center
- Press releases
- Corporate
Corporate
Janssen Therapeutics Announces Funding in Support of Improved Retention in Care and Access to Treatment for Blacks and African Americans Living with HIV in Southern United States and other Rural Areas
Award Funding Extends Company’s Ongoing Commitment to Supporting Underserved Communities in the United States
Mental Distress May Have a Greater Impact on Quality of Life Than Chronic Illnesses
A Johnson & Johnson Health and Wellness Solutions study shows managing mental wellness is critical to improve quality of life in patients with chronic illness
Johnson & Johnson Advances Commitment to Improve Global Health and Well-Being
A New Commitment to 2030 Sustainable Development Goals and Ongoing Support for Refugees
Johnson & Johnson Announces Agreement to Acquire Abbott Medical Optics
Acquisition to Strengthen Global Leadership in Eye Health Adding Cataract and Refractive Eye Surgery to Vision Care Portfolio
Johnson & Johnson Announces Ruling Related to REMICADE® in the District of Massachusetts Federal Court Hearing
Johnson & Johnson (NYSE: JNJ) today announced that the District of Massachusetts Federal Court has issued a ruling on a summary judgment motion filed by Celltrion Healthcare Co. Ltd. and Celltrion Inc
Johnson & Johnson Announces Completion of Acquisition of Vogue International LLC
Acquisition Strengthens Position in Hair Care
Johnson & Johnson Innovation and Janssen Research & Development Launch World Without Disease QuickFire Challenge
Largest QuickFire competition to date will award up to $500,000 in a research grant and entrance to Johnson & Johnson Innovation, JLABS, to promising transformational healthcare solution Challenge launched at 2016 BIO International Convention during the Bionic Innovation Forum
Yoshinori Ohsumi, Ph.D., Wins 2016 Dr. Paul Janssen Award for Biomedical Research
As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.